Cybin Inc PT receives Investment Bank Analyst Rating Update
- ByInvesting.com-
April 13 (Reuters) - Cybin Inc CYBN.NLB : * CYBIN ADVANCES IND-ENABLING STUDIES OF TWO PSYCHEDELIC MOLECULES, CYB003 AND CYB004 FOR INVESTIGATIONAL NEW DRUG APPLICATIONS
March 3 (Reuters) - Cybin Inc CYBN.NLB : * CYBIN INC. ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Cybin Inc. is a Canada-based biotechnology company. The Company is focused on progressing Psychedelics to therapeutics by engineering drug discovery platforms, drug delivery systems, formulation approaches and treatment regimens for mental health disorders. Across the various research and development programs, the Company is researching and developing an array of synthetic psychedelic active pharmaceutical ingredients (API) intended to be delivered through drug delivery systems, including sublingual films1, orally disintegrating tablets (ODT)2, via inhalation and via intravenous (IV). Its drug programs include Depressive Disorder (CYB003), Alcohol Use Disorder (CYB003), Anxiety Disorders (CYB004) and Neuroinflammation (CYB005). The Company focuses on the clinical development path for CYB004, the Company's deuterated Phase 1 N,N-dimethyltryptamine (DMT) molecule, for the treatment of anxiety disorders. Its subsidiaries include Cybin Corp., Natures Journey Inc, and others.
| Average | 4.38 (+594.44% Upside) |
| High | 7.00 |
| Low | 1.50 |
| Price | 0.63 |
| No. of Analysts | 4 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.05 | 0.05 | 0.05 | 0.00 | 0.00% | 0.00 | TSXV | |||
| 7.63 | 7.64 | 7.57 | -0.03 | -0.39% | 8.74K | Toronto | |||
| 1.17 | 1.18 | 1.17 | 0.00 | 0.00% | 0.00 | TSXV | |||
| 9.00 | 9.05 | 8.92 | +0.01 | +0.11% | 70.73K | Toronto | |||
| 2.24 | 2.27 | 2.16 | +0.1100 | +5.16% | 390.65K | Toronto | |||
| 26.06 | 26.41 | 26.05 | -0.54 | -2.03% | 3.99K | Toronto | |||
| 44.27 | 44.55 | 43.80 | +0.44 | +1.00% | 1.66M | Toronto | |||
| 23.01 | 23.10 | 22.76 | +0.35 | +1.54% | 3.17M | Toronto | |||
| 55.07 | 55.67 | 54.66 | +0.54 | +0.99% | 87.02K | Toronto | |||
| 1.50 | 1.59 | 1.465 | +0.040 | +2.74% | 1.96M | Toronto | |||
| 12.10 | 12.10 | 12.10 | +0.05 | +0.41% | 2.90K | Toronto | |||
| 22.30 | 22.72 | 21.96 | -0.46 | -2.02% | 454.64K | Toronto | |||
| 4.63 | 4.85 | 4.57 | -0.110 | -2.32% | 340.60K | Toronto | |||
| 100.64 | 101.27 | 100.19 | +0.12 | +0.12% | 1.00M | Toronto | |||
| 4.74 | 4.83 | 4.63 | +0.08 | +1.72% | 84.72K | Toronto |